secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senti Biosciences, Inc. (SNTI)
CIK:        0001854270
Form:       8-K
Filed at:   2026-08-20T20:25:39+00:00
Accession:  0001628280-26-058258
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Senti Biosciences subsidiary issues $4.0M convertible notes to Celadon; potential $60M CVR merger pending
--------------------------------------------------------------------------------

- On Aug 14, 2026, Senti Holdings issued $4.0M principal Senior Secured Convertible Notes to Celadon Partners SPV 24.
- Issuance under April 27, 2026 Securities Purchase Agreement; terms referenced from prior 8-Ks filed May 1 and May 26, 2026.
- Potential deal: Celadon affiliate to merge with Senti Holdings, issuing CVR worth up to $60M upon SENTI-202 regulatory/sales milestones.
- Preliminary proxy statement filed July 21, 2026; definitive proxy will be mailed to stockholders for vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1854270/000162828026058258/0001628280-26-058258-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1854270/000162828026058258/snti-20260814.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-058258

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer